Keely Blosh
Nurse Practitioner · Petoskey, MINPI 1013438530
Payments from drug & device makers
Across 263 payments — averaging $30.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Inspire Medical Systems, Inc.$2K
- AstraZeneca$2K
- GSK$662
- Regeneron Healthcare Solutions, Inc.$506
- Jazz Pharmaceuticals Inc.$377
- Verona Pharma, Inc.$352
- plus $2K from 21 others
What the payments were for
- Consulting fees$1502%
- Travel & lodging$1,02113%
- Food & beverage$6,30780%
- Education$4496%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Inspire Medical Systems, Inc. | 31 | $2,481 |
| AstraZeneca | 47 | $1,530 |
| GSK | 50 | $662 |
| Regeneron Healthcare Solutions, Inc. | 24 | $506 |
| Jazz Pharmaceuticals Inc. | 8 | $377 |
| Verona Pharma, Inc. | 16 | $352 |
| Insmed, Inc. | 10 | $268 |
| Sanofi | 8 | $211 |
| Harmony Biosciences LLC | 5 | $193 |
| Grifols USA, LLC | 8 | $182 |
| E.r. Squibb & Sons, L.L.C. | 5 | $143 |
| Boehringer Ingelheim | 9 | $141 |
| Amgen | 4 | $102 |
| Actelion Pharmaceuticals US, Inc. | 3 | $100 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $99 |
| Axsome Therapeutics, Inc. | 5 | $96 |
| Resmed Corp | 4 | $81 |
| Genentech USA, Inc. | 4 | $81 |
| Mylan Specialty L.p. | 5 | $80 |
| United Therapeutics Corporation | 2 | $58 |
| Pulmonx Corporation | 2 | $45 |
| Electromed, Inc. | 2 | $45 |
| Lilly USA, LLC | 2 | $33 |
| Noctrix Health, Inc. | 1 | $20 |
| ZOLL Respicardia, Inc. | 1 | $13 |
| La Jolla Pharmaceutical Company | 1 | $13 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,927 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 122 | $136,426 |
| Dupixent PenDupilumab | 23 | $96,003 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 69 | $70,128 |
| Breo ElliptaFluticasone/Vilanterol | 46 | $28,110 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 16 | $16,993 |
| Advair HfaFluticasone Propion/Salmeterol | 27 | $14,469 |
| Spiriva HandihalerTiotropium Bromide | 17 | $10,727 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $9,038 |
| SymbicortBudesonide/Formoterol Fumarate | 22 | $6,457 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 150 | $5,662 |
| Roflumilast | 54 | $5,500 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $4,548 |
| Montelukast Sodium | 88 | $1,406 |
| Ventolin HfaAlbuterol Sulfate | 12 | $1,093 |
| Armodafinil | 13 | $1,002 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta | $662 | $164,536168 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $1,530 | $76,58591 claims |
| Boehringer IngelheimStiolto Respimat, Combivent Respimat | $141 | $26,03131 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Other nurse practitioner in Petoskey
- Martha GoetzPetoskey$101K
- Joshua MartinPetoskey$31K
- Trudy DayPetoskey$10K
- Davida KrugerDetroit$1.8M
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Abubakir BabanDearborn$143K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.